CVRX INC. - COMMON STOCK

CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim

12 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

CVRx Announces Appointment of Two New Board Members

03 Sep 2024 08:30:00 By Nasdaq GlobeNewswire

CVRx Announces Increased Inpatient Payment for Barostim Procedure

02 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference

31 Jul 2024 16:27:00 By Nasdaq GlobeNewswire

CVRx Reports Second Quarter 2024 Financial and Operating Results

29 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024

15 Jul 2024 16:30:00 By Nasdaq GlobeNewswire

CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer

25 Jun 2024 06:50:00 By Nasdaq GlobeNewswire

CVRx to Present at the William Blair 44th Annual Growth Stock Conference

22 May 2024 08:30:00 By Nasdaq GlobeNewswire

CVRx Announces Key Senior Leadership Team Hires

16 May 2024 07:30:00 By Nasdaq GlobeNewswire

CVRx Reports First Quarter 2024 Financial and Operating Results

30 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024

16 Apr 2024 16:30:00 By Nasdaq GlobeNewswire

CVRx announces availability of additional data supporting long-term benefits of Barostim

15 Apr 2024 07:30:00 By Nasdaq GlobeNewswire

CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer

31 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

25 Jan 2024 16:05:00 By Nasdaq GlobeNewswire

CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024

11 Jan 2024 16:30:00 By Nasdaq GlobeNewswire

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans

08 Jan 2024 08:30:00 By Nasdaq GlobeNewswire

CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference

27 Dec 2023 16:30:00 By Nasdaq GlobeNewswire

CVRx receives FDA approval for expanded labeling of Barostim

26 Dec 2023 08:05:00 By Nasdaq GlobeNewswire

CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference

15 Nov 2023 16:21:43 By Nasdaq GlobeNewswire

CMS Increases Outpatient Payment for Barostim Procedure

03 Nov 2023 08:00:00 By Nasdaq GlobeNewswire